Individual Pharmacotherapy Management (IPM) with defined electronic patient and medication scores prevents far-reaching multidimensional polypharmacy risks and is universally applicable with AI support
Background: In multimorbidity and severe acute critical illness, polypharmacy [ref:1] is mostly unavoidable. There is no prevention tool that considers the full range of risks [ref:2] associated with adverse drug reactions (ADRs), intensified by drug-drug interactions (DDIs), drug-disease [for full text, please go to the a.m. URL]
Institutions
- Centre for Individualised Infection Medicine (DE)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2025-11-11
- DOI
- https://doi.org/10.3205/25gaa30
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00